Core Scientific Q1 2026 Earnings Report

Core Scientific EPS Results

• Actual EPS: -$1.06
• Consensus EPS: -$0.02
• Beat/Miss: Missed by -$1.04
• One Year Ago EPS: $1.25

Core Scientific Revenue Results

• Actual Revenue: $115.24 million
• Expected Revenue: $117.04 million
• Beat/Miss: Missed by -$1.79 million
• YoY Revenue Growth: +44.90%

Core Scientific Announcement Details

• Quarter: Q1 2026
• Date: 5/6/2026
• Time: After Market Closes
• Conference Call Date: Wednesday, May 6, 2026
• Conference Call Time: 4:30PM ET

Core Scientific (NASDAQ:CORZ) (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity. Its facilities are engineered for maximum energy efficiency and uptime, leveraging advanced cooling systems and redundant power feeds. This turnkey approach enables customers to focus on their blockchain strategy while relying on Core Scientific’s infrastructure expertise and operational support.

The company’s data centers are located across North America, with operations in states such as Georgia, Texas and Washington. These strategically positioned facilities provide access to competitively priced electricity markets and robust grid capacity. Core Scientific also offers high-performance computing (HPC) solutions that cater to emerging workloads in machine learning, artificial intelligence and large-scale data analytics, leveraging its existing infrastructure to meet growing demand for compute-intensive applications.

Core Scientific Q1 2026 Earnings Call Transcript

Key Takeaways

• Positive Sentiment: Closed a $3.3 billion CoreWeave project bond at 7.75% (net proceeds ~$2.9 billion) with a lockbox structure, enabling corporate‑level deployment of proceeds and supporting roughly $2 billion of planned 2026 capex.
• Positive Sentiment: Billing 243 MW today (≈$350M annualized GAAP colocation revenue), expects >450 MW by end of summer and the full 590 MW by early 2027, and raised CoreWeave cash gross profit target to 80–85%.
• Positive Sentiment: Accelerating development by investing ahead of leases—securing land, labor and long‑lead equipment to hit 12–14 month RFS targets and pursue campus growth (Pecos and Muskogee paths to ~1.5 GW each).
• Neutral Sentiment: Pursuing behind‑the‑meter and natural gas options (lead time ~12–14 months) with a mix of ownership and PPAs and active permitting efforts, which enables expansion but adds regulatory and execution complexity.
• Neutral Sentiment: Bitcoin mining will continue winding down through the year (only one or two sites expected running by year‑end) after monetizing most holdings, shifting the business mix toward colocation.

Presentation

[Operator]

Please note this conference is being recorded. I will now turn the conference over to your host, Jon Charbonneau, SVP, Investor Relations. Please go ahead, sir.

[Jon Charbonneau, VP of Investor Relations at Core Scientific]

Great, thank you. Good afternoon, welcome to Core Scientific's first quarter 2026 earnings call. Before we begin, I need to remind you the statements made on this call other than historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are based on our current expectations.

[Jon Charbonneau, VP of Investor Relations at Core Scientific]

Words such as anticipates, estimates, expects, intends and believes, and similar words and expressions are intended to identify forward-looking statements. These statements are subject to risks and uncertainties that could cause actual results to differ substantially. For further information on these risks and uncertainties, we encourage you to review the risk factors discussed in the company's reports on Form 10-Q and 8-K filed today with the SEC and the press release and slide presentation contained therein.

[Jon Charbonneau, VP of Investor Relations at Core Scientific]

The forward-looking statements we make today speak as of today, and we do not undertake any obligation to update any such statement to reflect events or circumstances occurring after today. Today's presentation is available on our website, investors.corescientific.com. The content of this conference call contains information that is accurate as of today, May 6, 2026. Joining me today from Core Scientific are our CEO, Adam Sullivan, Chief Operating Officer Matt Brown, and Chief Financial Officer Jim Nygaard. We will conduct a question-and-answer session after management's remarks. We will now begin with remarks from Adam.

[Adam Sullivan, CEO at Core Scientific]

Good afternoon, everyone, and thank you for joining us. platform designed to support the most demanding compute workloads in the market. Over the past year, we've translated that strategy into execution, delivering high density capacity at scale across multiple states. Those sites were an important starting point, but our first customer was never Core Scientific's full story.

[Adam Sullivan, CEO at Core Scientific]

Delivering these initial sites enhances our operating credibility and provides a significant capital foundation we need to scale meaningfully from here. We have shown clearly our ability to deliver at scale. Across five sites, we are now developing one of the largest multi-site AI infrastructure build-outs in the market. We are now earning revenue on approximately 245 MW, with another 200 MW expected to be earning revenue in the coming months. Our execution, combined with the favorable structure of our CoreWeave contracts, has enabled our next phase of growth.

[Adam Sullivan, CEO at Core Scientific]

Today, we closed on a $3.3 billion capital raise supported by that contract, with the proceeds to be used for future growth and the development of projects for other customers. The fact that we have five facilities fully leased and financed by our tenant is a meaningful differentiator. We have the ability to push the next phase of development in a disciplined way by securing the land, labor, and equipment to protect timelines and accelerate delivery.

[Adam Sullivan, CEO at Core Scientific]

As these new projects are leased, we expect opportunities for further financing to continue the cycle of our forward development go-to-market strategy. Our next phase of development has already begun. In late last year, we committed existing cash on hand to purchase equipment for our other existing sites. With the new secured financing, we are now accelerating development activity across multiple sites, including Pecos, Muskogee, Hunt, Dalton phase III, and Auburn.

[Adam Sullivan, CEO at Core Scientific]

This positions us differently in the market. We are not waiting for deal negotiations to conclude before advancing sites. With capital in place, we can move early, bringing RFS timelines within the 12 to 14-month timeframe that customers are actively trying to solve for. We are also scaling our campuses in a repeatable way. Today, we announced a path to approximately 1.5 GWs at Muskogee, closely following a similar plan at Pecos.

[Adam Sullivan, CEO at Core Scientific]

A key enabler of that scale is power strategy. Customers are increasingly focused on solutions beyond existing grid capacity, including behind-the-meter options. We are proactively positioning our sites to support those needs, including efforts to secure natural gas infrastructure where appropriate to enable future expansion. Pecos is a clear example.

[Adam Sullivan, CEO at Core Scientific]

We are actively converting the site from Bitcoin mining to high density colocation, with construction already underway and a pathway to RFS within 12 months. Muskogee is another. We see a path to 1.5 GWs of gross power supported by grid expansion, the Polaris acquisition, and behind-the-meter solutions, and we expect to deliver additional data center capacity outside of our current contract in late 2027. Stepping back, we are executing a repeatable model, secure strategic sites, invest ahead of contracts where appropriate, and create assets that are increasingly compelling as they approach readiness. That brings me to our commercial progress. We are engaging customers from a position of strength. Because development is already underway, our timelines are not dependent on contract timing, an important distinction in this market.

[Adam Sullivan, CEO at Core Scientific]

As we previously discussed, we are engaged in an exclusivity process with a hyperscaler across Pecos and Muskogee. That exclusivity is now expired. Three hyperscalers immediately engaged on those same sites, and we are now in active discussions. This reinforced both the strategic value of these assets and the depth of demand for large scale, high density capacity. It also informed how we approach exclusivity going forward. While it likely remains a necessary part of some deal negotiations, it must also include clear milestones. In a market like this, we will not keep high value assets off the market longer than necessary. Our conversations with potential customers have increased significantly since the beginning of the year. Hyperscalers remain our primary focus, and we are also seeing growing engagement from chip makers, AI labs, and neocloud providers.

[Adam Sullivan, CEO at Core Scientific]

These emerging customer segments represent meaningful opportunity, though they often require additional credit support. We are actively working with customers and financing partners on structures that can support long term financable commitments. Stepping back, our position is clear. We are building a scaled, high density digital infrastructure platform with a diversified site portfolio. We are deploying capital to secure timelines and accelerate delivery. We are also seeing strong customer demand. Based on our execution, capital position, and commercial momentum, we are confident in our ability to continue expanding and creating long term value for our customers and our shareholders. With that, I'll turn the call over to Matt Brown to provide more details on our operations and development progress. Matt.

[Matt Brown, COO at Core Scientific]

Thanks, Adam. As we reflect on the first quarter, our operational priorities may remain clear. Execute on our existing build pipeline, bring capacity online efficiently, and position the business for the next phase of large scale expansion. Demand for high performance compute infrastructure remains strong, and we have focused on aligning our delivery timelines, supply chain readiness, and power strategies to meet that demand. I'll begin with an update on our CoreWeave dedicated facilities, where we continue to execute at pace and at scale. Today, I am pleased to announce that we have delivered 243 MW of billable capacity to CoreWeave. This includes a milestone with a full turnover of both our Marble, N.C. and Dalton, Ga. phase I data centers. At Marble, we completed construction and successfully transitioned the entire facility into operations, bringing 65 MW of billable capacity online.

[Matt Brown, COO at Core Scientific]

At Dalton phase I, we likewise achieved full site handover and delivery 30 MW into service. These milestones reflect the team's ability to execute efficiently at scale, transition assets seamlessly from construction to revenue generation, and consistently align to customer timelines, all of which remain critical as we continue to move forward. Across our remaining contracted sites, we will continue delivering billable megawatts over the coming months while scaling execution on the CoreWeave contract, positioning us to deliver more than 450 billables by the end of the summer, while remaining on track to deliver the full 590 MW by the early 2027. Turning to our non-CoreWeave developments, where we are advancing our development strategy.

[Matt Brown, COO at Core Scientific]

Our Pecos, Texas campus is one of our most significant development opportunities, with a plan to scale from 300 MW to 1.5 GW through a multi-pronged expansion strategy. At the core is our power roadmap. We've secured an additional 300 MW and are advancing a mix of grid connected and behind-the-meter solutions to support long term growth. The behind-the-meter strategy leverages low emission generation and concludes the construction of a linear gas pipeline to the campus. Together, these efforts are designed to accelerate time to power, enhance resilience, and reduce the supply chain risk while enabling us to meet hyperscale demand. In parallel, construction of our initial 431,000 sq ft, 185 MW facility is progressing from civil work into foundation phases with precast walls arriving for vertical construction.

[Matt Brown, COO at Core Scientific]

Long lead items equipment has been secured, helping reduce execution risk and support timelines. We are also advancing infrastructure for high density colocation, including redundant fiber capacity and a new regional interconnect point in Midland, Texas, linking back to the Pecos campus. At our Muskogee, Oklahoma campus, today, we announced plans for the expansion of the site to 1.5 MW of gross power or approximately 1 GW of leasable capacity. Similar to Pecos, this expansion will leverage a combination of behind-the-meter infrastructure and utility supply power, including the roughly 440 MW acquired through the Polaris transaction. With our general contractor already secured on site, we have begun development of the first 82.5 MW building, with initial delivery expected in the second half of 2027.

[Matt Brown, COO at Core Scientific]

Finally, turning to other development sites, Hunt County, Texas, Dalton, Georgia, phase III, and Auburn, Alabama, each continues to advance through pre-construction milestones and remains on track to meet their initial delivery timelines. In closing, as we look ahead, we remain confident in our ability to execute against our commitments and capture opportunities in front of us. The combination of strong demand, a growing portfolio of scale developments, and continued progress on our power infrastructure strategies position us well for the quarters ahead. With that, I'll turn it over to Jim.

[Jim Nygaard, CFO at Core Scientific]

Thanks, Matt. During the first quarter, we reached an important inflection point as our colocation revenue scaled to a level sufficient to cover operating costs and begin expanding margins.

[Jim Nygaard, CFO at Core Scientific]

This marks a meaningful milestone in our transition, with colocation now becoming an important driver of our overall financial profile. Today, we are billing for 243 MW, which equates to more than $350 million of annualized colocation GAAP revenue, with significant additional capacity expected to begin billing over the next several months. As a reminder, under GAAP, revenue from the CoreWeave contract is recognized on a straight-line basis over the 12-year lease term, effectively pulling escalators forward. From a Bitcoin mining perspective, we remain focused on optimization and are running that business to help offset contractual power costs as we continue the transition toward high-density colocation. Going forward, we expect mining activity to continue winding down over the course of the year with a meaningful step down in miners online in the second half.

[Jim Nygaard, CFO at Core Scientific]

Earlier this year, we monetized a significant portion of our Bitcoin holdings and currently retain only a modest amount of Bitcoin on the balance sheet. Moving on to costs. First quarter SG&A on a cash basis was just over $30 million. While we are not providing explicit SG&A guidance, we believe this level represents a reasonable baseline for corporate expenses going forward, with the potential for opportunistic investments to support growth over the next few years. Separately, you may have noticed that we increased our target cash gross profit range for the CoreWeave contract to 80%-85%, up from our original target of 75%-80%. We first introduced that target roughly two years ago, and today we have much greater visibility into the associated cost structure, given we are now billing for a meaningful portion of the contracted megawatts.

[Jim Nygaard, CFO at Core Scientific]

With that operating backdrop, let me turn to capital formation, where today marked another major milestone for Core Scientific. We closed our previously announced $3.3 billion CoreWeave project bond financing at a 7.75% interest rate, which we view as highly attractive cost of capital for a financing of this scale. After closing costs and funding the required debt service reserve account, net proceeds were approximately $2.9 billion. For additional context, the bonds include a lockbox structure, which is a cash control mechanism where project revenues are paid directly into a designated account and then applied through the indenture-defined cash waterfall, first to operating expenses, then to debt service, and finally to other uses permitted by the indenture.

[Jim Nygaard, CFO at Core Scientific]

Unlike a traditional project finance structure where a lockbox is created to fund a specific project under development, our structure enables the distribution of the vast majority of offering proceeds up to the corporate level to facilitate investments in a variety of new projects outside the box. Going forward, the lockbox will service the debt secured by CoreWeave contracted site assets and cash flows. From this perspective, the transaction significantly strengthens our consolidated capital position, validates the quality and predictability of our contracted cash flows, and gives us the ability to execute the next phase of our growth plan with greater flexibility, speed, and certainty. We expect to deploy roughly $2 billion of total capital expenditures in 2026.

[Jim Nygaard, CFO at Core Scientific]

This includes approximately $700 million for both the Hunt County, Texas, site acquisition, which closed yesterday, and the Polaris acquisition at our Muskogee, Oklahoma, site announced earlier today, as well as expenditures to begin pre-seeding approximately 1 GW of new billable capacity. This includes long lead time equipment procurement and various site development and utility support activities across multiple project locations. We are strategically positioning the business to sign attractive new customer contracts with capacity outside of CoreWeave available for delivery starting in early 2027. The platform we are building together with cost-effective capital we have secured for new project equity investments is differentiated in the market, and we believe it positions Core Scientific to create meaningful long-term shareholder value. Lastly, we recently welcomed Jorge Rey as our Chief Accounting Officer, further strengthening our finance and accounting team.

[Jim Nygaard, CFO at Core Scientific]

Jorge brings valuable accounting and public company reporting experience, and his leadership will be important as we continue to scale the business and support our next phase of growth. I'll now turn the call over to the operator for questions.

[Operator]

Thank you. Our first question will come from Brett Knoblauch with Cantor Fitzgerald.

[Brett Knoblauch, Analyst at Cantor Fitzgerald]

Hi, guys. Thanks for taking my question and congrats on the site expansion at Texas and Muskogee. I guess maybe just on the Hyperscale exclusivity, it expired. Clearly, there's demand with additional tenants kind of, you know, backfilling that. Could you maybe shed light on, you know, why it expired, why it didn't progress? Is there anything that maybe those sites were not of interest or, you know, they weren't interested in or just, you know, some more color around that dynamic?

[Adam Sullivan, CEO at Core Scientific]

Absolutely. Thank you, Brett Knoblauch. Those sites, as you mentioned, are incredibly attractive, both Pecos and Muskogee, given their ability to scale, represent tremendous opportunity for hyperscaler. As we noted in prepared remarks, three hyperscalers immediately engage. They're incredibly attractive sites. Really, with the one that we're under exclusivity with, it's hard to determine the exact reasons why. For us, we got to the end of the exclusivity and we thought this is the best time for us to bring these back to market because hyperscalers were knocking at the door and asking questions about the sites, and we knew we couldn't have an opportunity to bring another hyperscaler into the fray.

[Adam Sullivan, CEO at Core Scientific]

We feel great about our position today, given the competitive dynamic.

[Brett Knoblauch, Analyst at Cantor Fitzgerald]

Perfect. Yeah, maybe just one follow-up. You know, it seems like kind of the AI pendulum swinging into full, you know, bull mode here. You guys do have, I believe, a lot of capacity available to these kind of RFS, you know, by early 2027. Do we think we're closer to maybe a second tenant today than we were, you know, when you guys reported 4Q in early March?

[Adam Sullivan, CEO at Core Scientific]

Yeah, I mean, when you look across our site portfolio, you know, we have five sites with first data halls RFS in 2027. It's incredibly unique position given the different size and scale and geography spread that we have inside our portfolio. You know, we're in conversations with all of the hyperscalers, chip makers, AI labs, neo clouds. You know, we're in a unique position here, just given the asset spread that we have. I would say definitely across the entire site portfolio, we are closer than we were before.

[Brett Knoblauch, Analyst at Cantor Fitzgerald]

Awesome. Really appreciate it. Thank you, guys.

[Adam Sullivan, CEO at Core Scientific]

Thanks, Brett.

[Operator]

Our next question will come from John Todaro with Needham & Company.

[John Todaro, Analyst at Needham & Company]

Hey, guys, thanks for taking my question and congrats on the expansion of power. Two from me. I guess just one, going back to the other three hyperscalers you're now in conversation with. I guess just if we frame it up, was there already some dialogue at some point? I mean, obviously it's a little bit of a limited universe, but like should we be thinking it's kind of starting the process anew with them or there's already been, you know, at some point along the way, pretty far along where, you know, just we could get something maybe a bit sooner than necessarily restarting the process?

[Adam Sullivan, CEO at Core Scientific]

Yeah. Thanks, John. I mean, our relationship with these groups is not new. We are engaged with them on other sites. This was just really bringing back, you know, both Pecos and Muskogee back to the table. That's really why we are able to immediately re-engage with those customers.

[John Todaro, Analyst at Needham & Company]

Got it. Understood. That's very helpful. Just, you know, you mentioned starting some of the process on building out some of these assets. You know, it sounds like before a lease gets done at some of them. Just kind of, I guess, are there any guardrail on how much CapEx you would start putting forward before getting a lease?

[Adam Sullivan, CEO at Core Scientific]

Yeah, I mean, the way we're thinking about it right now is we wanna take the first data hall to full RFS. As part of that means we're securing the labor, securing the trades. We're securing long lead equipment. We're putting ourselves in a position where if a customer signs really within any time period leading up to the RFS of the first data hall, we can just continue to extend all of that labor that we have secured on site. That's kind of our guardrail right now in terms of where we sit.

[Adam Sullivan, CEO at Core Scientific]

We feel very confident in the strategy and the ability to show the progress that we're making across each of these sites to customers is really what's forcing the engagement here because everyone's incredibly interested in capacity that's getting delivered in 2027 right now.

[John Todaro, Analyst at Needham & Company]

Yep, understood. Thank you for that, gentlemen.

[Adam Sullivan, CEO at Core Scientific]

Thank you.

[Operator]

We'll go next to Timothy Horan with Oppenheimer.

[Timothy Horan, Analyst at Oppenheimer]

Thanks, guys. Do you have a rough idea when you might sign a contract? Can you maybe just talk about the pricing trends, you know, at a high level?

[Adam Sullivan, CEO at Core Scientific]

Yeah, I mean, I would just say we're actively engaged right now across every major group, and we feel very confident based on where we sit today versus where we sat three months ago. The only thing that's changed is our assets have continued to build more value. We've continued to deploy more capital, and we've continued to get closer to the RFS date. We have high confidence in the customer conversations that we're having today. If you could just remind me, Tim, what was your second question?

[Timothy Horan, Analyst at Oppenheimer]

Yeah, you know, you know, what are you seeing in the pricing trends or the pricing of the new contracts you expect?

[Adam Sullivan, CEO at Core Scientific]

Yeah. I mean, I think you could expect to see pricing continue to firm up. You know, really that's the result of both labor and equipment continuing to inflate. What you're just seeing is a similar move in pricing.

[Timothy Horan, Analyst at Oppenheimer]

Just lastly, behind-the-meter power, can you give us just a sense of what's the lead time on that? Ultimately, how will your cost for, you know, build your own versus the grid, you know, compare?

[Adam Sullivan, CEO at Core Scientific]

Yeah. No, I mean, right now what we're looking at really is to deploy behind-the-meter solutions, you know, anywhere from about 12-14 months. The great part is for us is, you know, these are opportunities given the locations that we have available to us, is really gonna represent a great opportunity for continuing to expand at those sites. You know, the other site that we haven't talked about, Hunt. You know, Hunt has the opportunity to potentially bring behind-the-meter, that's something that we're still in the evaluation phase today. Haven't necessarily done as much of the due diligence that we've done across Pecos and Muskogee and the work that is currently being performed there.

[Timothy Horan, Analyst at Oppenheimer]

Is the ultimate cost of a customer about the same as grid or a little bit more?

[Adam Sullivan, CEO at Core Scientific]

It's about the same. I mean, the economics for us as a developer look very similar. The cost to the end tenant to, on a blended basis, per power rate, is not materially different.

[Timothy Horan, Analyst at Oppenheimer]

Thank you.

[Operator]

Michael Donovan with Compass Point has our next question.

[Michael Donovan, Analyst at Compass Point]

Hi, guys. Thanks for taking my question. Another question on behind the meter. The Muskogee announcement this morning referenced Oklahoma's behind-the-meter legislation. Can you explain what that legislation changes for Core Scientific's ability to develop and whether it gives Muskogee a timing or cost advantage versus opportunities in Texas?

[Adam Sullivan, CEO at Core Scientific]

Yeah, I mean, Kevin Stitt has been a big advocate of bringing behind-the-meter opportunities to the state of Oklahoma. You know, obviously you saw Kevin Stitt's quote in the press release today. You know, Oklahoma is focused on figuring out how to bring more generation to the state. Our ability to execute at Oklahoma, I wouldn't say it's necessarily any easier or any more difficult than our site in Pecos, but we definitely have the support of the government there to continue to bring more generation to the state.

[Michael Donovan, Analyst at Compass Point]

Great. Thanks. One follow up, if I may. Have you contemplated owning the generation assets or would you be solely partnering with a power developer? How are you thinking about redundancy?

[Adam Sullivan, CEO at Core Scientific]

Yeah, I'll take the first part of that question and then I'll hand it over to Matt to take the question about redundancy. You know, as we evaluate the behind the meter solutions, there are potentially some solutions that we would own ourselves and there are others that we would work through a third party that would provide us a PPA and we would be paying for those over a course of time would be included in the power price. There's a few different methods that we could go down. It really just comes down to the economics question as well as who the behind the meter solution is from. Matt, you want to talk about redundancy?

[Matt Brown, COO at Core Scientific]

To include in that is belongs the maintenance and operation of the behind-the-meter generation comes with that PPA agreement as well. From a redundancy standpoint, obviously when we're building behind-the-meter, redundancy becomes much more critical in terms of when you're building high availability services. We'll think about redundancy in terms we need to be able to support the full load of the portion of the campus that we're powering from behind-the-meter, under maintenance conditions, meaning that we need to be able to take some of that equipment offline for maintenance, maintain full load, and have redundant capacity still online and available in the event of a failure.

[Matt Brown, COO at Core Scientific]

You can almost think about that as a minimum, an N plus one configuration, maybe an N+2% or an N +20% or N+30% type of redundancy scheme.

[Michael Donovan, Analyst at Compass Point]

Great. Appreciate it, and congrats on the progress.

[Matt Brown, COO at Core Scientific]

Thank you.

[Operator]

Moving on to Joseph Vafi with Canaccord.

[Joseph Vafi, Analyst at Canaccord]

Hey, guys. Good afternoon. Congrats on the progress. Thanks for taking the question. Just wondering how you're managing perhaps the labor side of the builds here. I'm not quite sure if you've if you're employing a few large GCs on the builds or, you know, are you looking at construction labor as any constraint in the market right now? Thank you.

[Matt Brown, COO at Core Scientific]

Yeah. No, great question. Labor is one of the primary constraints of the market, if not depending on which market we're talking about. When we look at nationally, labor is a big issue. It's one of the reasons why we think we have an advantage by being able to proactively invest in development of these sites, being able to secure and tie up the labor through our projected RFS and scaling beyond that. In terms of how we're doing that, we have two large GCs sort of executing our sites and development today. Those GCs have a lot of leverage in the marketplace, being able to secure electrical contractors, mechanical contractors, civil, et cetera.

[Matt Brown, COO at Core Scientific]

All of those, all except for probably one site, are already fully mobilized and executing our developments, as we speak.

[Joseph Vafi, Analyst at Canaccord]

Great. Thank you very much.

[Operator]

We'll go next to Paul Golding with Macquarie Capital.

[Paul Golding, Analyst at Macquarie Capital]

Thanks so much. Congrats on the progress. Just wanted to ask on these behind-the-meter opportunities that you've been discussing. I know you just mentioned in response to another question that you might partner with someone who would give you a PPA or you might look at an opportunity to do it yourself behind-the-meter in terms of generation. How is the air quality component of that structured, or how do you see that potentially being structured? Do you have to still go to market and apply for those emissions permits, or would a partner that you're speaking with already have that in hand? I have a follow-up. Thank you.

[Matt Brown, COO at Core Scientific]

Yeah. No, great question. As we sort of, I mentioned in our prepared remarks is the technologies that we're gonna get behind and support for all of our behind-the-meter sites are gonna be technologies that are low emissions, generally. That will give you a little bit of insight as to what we're not thinking about from that standpoint. To go and to talk about sort of the permitting standpoint, yes. We will have to certainly go and apply for air quality permits for many of these deployments. In some cases, that will be in participation with the behind-the-meter operator or supplier. In other cases, we'll be doing that on our own.

[Matt Brown, COO at Core Scientific]

I'll say that in both Pecos and Muskogee, we're already down, kind of, far down the path of sort of our air quality studies for the implementation of those solutions.

[Paul Golding, Analyst at Macquarie Capital]

Got it. Thanks so much. I was just hoping you could also give a little more detail around some of the puts and takes that enabled you to raise the run rate margin profile on the existing energized and billable capacity from that 75% to 80% to 85%. Thank you.

[Jim Nygaard, CFO at Core Scientific]

Two years ago, when we signed the CoreWeave original CoreWeave contract, we had a scope of service contemplated in that deal. I think we had an element of conservatism knowing that we hadn't broken ground on the project at that point, knowing that we were gonna be deploying over a fairly lengthy period, to have a what I would call a very solid perspective on what we think we could have delivered. Once you're two years after the fact, you're into it, and we've got, you know, more experience under our belt on the specificity of actual heads that are gonna be devoted to the activities and the contractors that we're using and actually have deployed on site, it's really just a true up of that experience.

[Jim Nygaard, CFO at Core Scientific]

We feel good that we, you know, we're at a margin level that we can deliver today, and we're, we felt more confident that we could be a bit more prescriptive of where we think we're gonna end up.

[Paul Golding, Analyst at Macquarie Capital]

Great. Thanks so much.

[Operator]

Our next question comes from George Sutton with Craig-Hallum.

[George Sutton, Analyst at Craig-Hallum]

Thank you. As you begin to market to the chipmakers and the neo clouds, I'm just curious, do you have a bifurcated sales portfolio where some of the sites and some of the maybe even parts of locations are being marketed to those folks versus the hyperscalers? How is that working through the system?

[Adam Sullivan, CEO at Core Scientific]

Yeah, I mean, really, we're showing both chipmakers, neo clouds, labs. We're showing them the same sites that we are also showing to hyperscalers. I mean, as we work through these processes, oftentimes, you know, they're migrating to one or another site. In reality, you know, we're showing our entire portfolios to each of the customers that come through our door.

[George Sutton, Analyst at Craig-Hallum]

One other question relative to the decision to execute ahead of the contracts. How does the negotiation get altered with some of these potential customers when you've, you know, you've secured the supply chain and you're kind of moving forward? Does that accelerate discussions? Does that keep them more engaged? Can you just walk through that thought process?

[Adam Sullivan, CEO at Core Scientific]

Yeah, I mean, it definitely keeps them more engaged. I mean, they rarely see sites that come across their desk where there's an RFS timeline really within, you know, 18 months, even more so, you know, less than that. For us, you know, being able to show photos and videos of sites with active construction going on, and the list of equipment that are on order, that dramatically changes the dynamic of the discussions, because this isn't just a, you know, a photo of a piece of land. You know, this is an active construction site, actively progressing towards building a data center.

[George Sutton, Analyst at Craig-Hallum]

Gotcha. Thank you, Adam.

[Operator]

We'll go next to Jon Hickman with Ladenburg Thalmann.

[Jon Hickman, Analyst at Ladenburg Thalmann]

Hi. Thanks for taking my question. This is a little bit esoteric, but now that you're well into your buildout for CoreWeave, could you comment on the experience? Like, what was harder than you thought? What was easier? Where do you think you have a competitive advantage now that you've, you know, put that much, that many megawatts into production?

[Matt Brown, COO at Core Scientific]

Yeah. No, it's actually a great question. The kind of reflecting on that, I think the thing that was much more difficult than we certainly gave it credit for was actually executing on brownfield conversions, which is why everything you see that we're doing forward is actually a greenfield site with a very highly standard basis design that allows us to get kind of leverage over our supply chain and be super predictable in terms of our build, our delivery dates. brownfield sites are highly unpredictable. They require a lot of customization. It's a lot of effort to try to retrofit an existing building. While sometimes that can be faster, it also comes with a lot more complexity.

[Matt Brown, COO at Core Scientific]

That's what I would say is probably our biggest, one of our biggest lessons learned out of this.

[Jon Hickman, Analyst at Ladenburg Thalmann]

Okay. Competitively, now that you've learned that, where do you think you are with other people that are trying to, I mean, there's many other competitors that are trying to build data centers?

[Matt Brown, COO at Core Scientific]

Yeah, the great part of.

[Jon Hickman, Analyst at Ladenburg Thalmann]

Why would I choose you, kind of?

[Matt Brown, COO at Core Scientific]

Yeah. I think the great part of this is that we've had 5 sites not practice on, but we have been executing these high-density builds across all the CoreWeave locations. We've been able to iterate on those designs. I mean, we've executed more than 150 design changes along the way across the portfolio. That gives us a little bit of a little bit of ahead of the game in terms of what doesn't work and what works well. All of those learnings have been sort of culminated and formulated into a go forward build strategy. I think we have just the advantage of learning all those lessons firsthand in real time. We won't make those mistakes going forward.

[Jon Hickman, Analyst at Ladenburg Thalmann]

Great. Thanks. Congratulations on the new deals.

[Operator]

Our next question comes from Nick Giles with B. Riley Securities.

[Henry Hurl, Analyst at B. Riley Securities]

Thank you, operator. This is Henry Hurl on for Nick Giles. I wanted to ask about the change in your approach to exclusivity. In what scenarios would you go into it? And then you also mentioned being in contact with several counterparties. Would you expect to announce exclusivity if you were to enter into one? Thanks.

[Adam Sullivan, CEO at Core Scientific]

Yeah. Thanks, Henry. You know, I wouldn't say that we would expect to announce, you know, in the interim between quarters. Really what we've migrated to here is moving to a milestone arrangement method, which allows us to ensure that the cadence is moving at the pace that we would expect it to in a deal that would move towards closing. That allows us to bring a site back on market if we don't feel like the pace and cadence is necessarily where we would like it to be. You know, we've migrated to this strategy. We're executing on it now, and we feel like it gives us the best shot on goal given the demand that we're seeing in the market today.

[Henry Hurl, Analyst at B. Riley Securities]

Understood. Thanks for that. Then on winding down your Bitcoin mining operations in the coming quarters, do you guys have a definitive target date to be fully out of that business, or will it kind of act as a small hedge going forward? Thanks.

[Adam Sullivan, CEO at Core Scientific]

No, I would say, you know, over the course of the remainder of this year, the Bitcoin mining business is going to continue to migrate lower. By the end of this year, we will only have one or potentially two sites operating Bitcoin mining.

[Henry Hurl, Analyst at B. Riley Securities]

Thank you. Continue. Best of luck.

[Adam Sullivan, CEO at Core Scientific]

Thanks, Henry.

[Operator]

Moving on to Stephen Glagola with KBW.

[Stephen Glagola, Analyst at KBW]

Hey, thanks for the question. Adam, I just, you know, wanted to touch base again on the challenges on securing the leasing commitments at Pecos and Muskogee. You know, from my standpoint, it would seem like you have strong leverage there. You know, the sites have near term power. You can point to your execution and the CoreWeave buildouts to date. I guess, like, maybe my question is, are you seeing, like, hyperscalers become more selective in their choice of development partners? If so, you know, how is that influencing demand or deal timing?

[Adam Sullivan, CEO at Core Scientific]

Yeah, I mean, I think the interesting part about this is the exclusivity that expired, that customer is still at the table and still interested in those sites. I think you are seeing that broadly across the market. You know, you're seeing, you know, repeat deals across some of the developers, especially on the private side. I would agree with that. Also, you know, they're also looking for experience in the development of this type of infrastructure. This is different than the traditional data center infrastructure. Given the experience that we have and our ability to show them 5 sites that we've built, 590 megawatts in progress of critical IT load, that's a differentiator, and that really puts us in a different bucket here.

[Adam Sullivan, CEO at Core Scientific]

You know, as you mentioned, we have great experience building. We have sites under construction, and, you know, it really puts us into a pretty unique category in this industry.

[Stephen Glagola, Analyst at KBW]

Thank you.

[Operator]

This now concludes our question and answer session. Ladies and gentlemen, thank you for your participation. This does conclude today's teleconference. You may disconnect your lines. Have a wonderful day.

Participants

Executives

• Jim Nygaard, CFO
• Jon Charbonneau, VP of Investor Relations
• Matt Brown, COO

Analysts

• Adam Sullivan, CEO at Core Scientific
• Brett Knoblauch, Analyst at Cantor Fitzgerald
• George Sutton, Analyst at Craig-Hallum
• Henry Hurl, Analyst at B. Riley Securities
• John Todaro, Analyst at Needham & Company
• Jon Hickman, Analyst at Ladenburg Thalmann
• Joseph Vafi, Analyst at Canaccord
• Michael Donovan, Analyst at Compass Point
• Paul Golding, Analyst at Macquarie Capital
• Stephen Glagola, Analyst at KBW
• Timothy Horan, Analyst at Oppenheimer